SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Talk to the deal team
Related deals
AYANDA CAPITAL has added a new investor to its shareholding
A new investor, Thierry Jacobs, has joined AYANDA CAPITAL S.L.’s shareholding with a minority stake.
Learn moreGoldlight has been acquired by Grenardi Group
AS Grenardi Group, the largest Baltic jewelry retailer, has acquired Goldlight.
Learn moreNuzoa has acquired Dinazoo
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Dinazoo. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn more